[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335188-105":59,"doc-detail-335188-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","lymphocyte-antigen-6-family-member-e-suppresses-apoptosis-and-promotes-pancreatic-cancer-growth-and-migration-via-wntcatenin-pathway-activation","Lymphocyte antigen 6 family member E suppresses apoptosis and promotes pancreatic cancer growth and migration via Wnt/β‑catenin pathway activation","","Pancreatic cancer remains a leading cause of cancer-related death and lacks reliable biomarkers to predict prognosis or guide therapy. This study investigates lymphocyte antigen 6 family member E (LY6E) in pancreatic cancer using comprehensive bioinformatic analyses and multiple experimental approaches, including Western blotting, immunohistochemistry, flow cytometry, cell assays, and animal models. LY6E is markedly upregulated in pancreatic cancer and associates with poor prognosis. Functional assays show LY6E knockdown suppresses proliferation, invasion, and migration while promoting apoptosis, whereas LY6E overexpression produces the opposite effects.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/lymphocyte-antigen-6-family-member-e-suppresses-apoptosis-and-promotes-pancreatic-cancer-growth-and-migration-via-wntcatenin-pathway-activation/335188/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/lymphocyte-antigen-6-family-member-e-suppresses-apoptosis-and-promotes-pancreatic-cancer-growth-and-migration-via-wntcatenin-pathway-activation/335188.png","ImageObject",300,407,{"name":92,"@type":93},"Asher","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role does LY6E play in pancreatic cancer progression?","Question",{"text":112,"@type":113},"LY6E is significantly elevated in pancreatic cancer and is associated with poor prognosis. Functionally, LY6E knockdown reduces tumor cell proliferation, invasion, and migration while increasing apoptosis.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does LY6E affect apoptosis in pancreatic cancer cells?",{"text":117,"@type":113},"LY6E knockdown enhances apoptosis, evidenced by increased cleaved caspase 3 and changes in the Bcl-2/Bax ratio. LY6E overexpression inhibits apoptosis.",{"name":119,"@type":110,"acceptedAnswer":120},"Which signaling pathway is linked to LY6E’s effects?",{"text":121,"@type":113},"Mechanistically, LY6E downregulation suppresses the Wnt/β-catenin signaling pathway. This pathway activation is connected to enhanced pancreatic cancer growth and migration.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},335188,1790100713,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":4},687197207639,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nLymphocyte antigen 6 family member E suppresses apoptosis and promotes pancreatic cancer growth and migration via Wnt/β‑catenin pathway activation  \nKenan Cen1,3,5, Jingyao Zhou2,5, Xuejia Yang3,5, Yangyang Guo3 & Yanyi Xiao1,4*  \nPancreatic cancer (PC) is the primary cause of cancer‑related mortality. Due to the absence of reliable biomarkers for predicting prognosis or guiding treatment, there is an urgent need for molecular studies on PC. Lymphocyte antigen 6 family member E (LY6E) is implicated in uncontrolled cell growth across various cancers. However, the precise mechanism of LY6E in PC remains unclear. Here, we conducted comprehensive bioinformatic analyses using online tools and R‑ × 64–4.1.1, complemented by experimental validation through Western blotting, immunohistochemistry, immunosorbent assays, flow cytometry, cell assays, and animal models. Our findings reveal significantly elevated expression of LY6E in PC, correlating with poor prognosis. LY6E knockdown inhibited proliferation, invasion, and migration of PC cells, while enhancing apoptosis evidenced by increased cleaved caspase 3 levels and alterations in the Bcl‑2/Bax ratio. Conversely, LY6E overexpression promoted PC cell proliferation and migration, and inhibited apoptosis. Mechanistically, LY6E downregulation suppressed the Wnt/β‑catenin signaling pathway. In vivo studies demonstrated that LY6E suppression attenuated tumor growth in murine models. Additionally, LY6E suppression resulted in reduced tumor growth in mice. In conclusion, our study confirms the significant role of LY6E in the progression of  \nPC. LY6E, serving as an independent prognostic indicator, has the potential to serve as a valuable biomarker for PC to inform treatment strategies.  \nKeywords Pancreatic cancer, LY6E, Prognosis, Apoptosis, Wnt/β-catenin  \nPancreatic cancer (PC) is a highly malignant solid tumor of the digestive system with an unfavorable prognosis, been a leading cause of cancer-related deaths in recent decades1. The number of diagnosed cases worldwide has doubled from 196,000 in 1990 to 441,000 in 20172. The rise in incidence can be attributed not only to increased life expectancy and unhealthy habits but also to more precise and comprehensive early detection methods3–6. However, due to in-depth research and better management of PC, the mortality rates associated with this disease are on the decline7. Accumulating evidence supported that cancer is a special disease closely related with abnormal genome; there is no exception to PC8–10. Actually, genomic studies of PC have been explored and some fascinating discoveries have been used to guide treatment, all of which led to our preliminary triumph over the PC. Despite these advancements, further exploration at the molecular level is urgently needed due to the high heterogeneity and aggressiveness of PC.  \nResearch on a notable cell surface protein associated with cancer, lymphocyte antigen 6 family member E (LY6E), encoded by the LY6E gene on human chromosome 8, has garnered attention11. LY6E is a cell membrane protein associated with interferon-induced glycosylphosphatidylinositol (GPI) and is found to be significantly overexpressed in various solid tumors, including pancreatic cancer12. A recent study suggests that high expression  \n1The Dingli Clinical College of Wenzhou Medical University, Wenzhou 325000, Zhejiang Province, China. 2Department of Pharmacy, Taizhou Central Hospital, Taizhou, China. 3Zhejiang Key Laboratory of Intelligent Cancer Biomarker Discovery and Translation, The First Affiliated Hospital, Wenzhou Medical University, Wenzhou 325035, China. 4Department of Thyroid and Breast Surgery, The Second Affiliated Hospital of Shanghai University, Wenzhou 325000, Zhejiang Province, China. 5These authors contributed equally: Kenan Cen, Jingyao  \nZhou and Xuejia Yang.* email: [15967411128@163.com](15967411128@163.com)  \n[www. nature.c","cbCaime23JR7kmLB","https://ap.wps.com/l/cbCaime23JR7kmLB","pdf",13719882,16,"English","# Background\n## Pancreatic cancer burden and biomarker need\n## LY6E in cancer biology\n## Tumor microenvironment and immune relevance\n# Methods\n## Bioinformatic analysis\n## Experimental validation\n# Results\n## LY6E expression and clinical association\n## Effects on proliferation, invasion, migration, and apoptosis\n## Wnt/β-catenin pathway involvement\n## In vivo tumor growth effects\n# Conclusion","[{\"question\":\"What role does LY6E play in pancreatic cancer progression?\",\"answer\":\"LY6E is significantly elevated in pancreatic cancer and is associated with poor prognosis. Functionally, LY6E knockdown reduces tumor cell proliferation, invasion, and migration while increasing apoptosis.\"},{\"question\":\"How does LY6E affect apoptosis in pancreatic cancer cells?\",\"answer\":\"LY6E knockdown enhances apoptosis, evidenced by increased cleaved caspase 3 and changes in the Bcl-2/Bax ratio. LY6E overexpression inhibits apoptosis.\"},{\"question\":\"Which signaling pathway is linked to LY6E’s effects?\",\"answer\":\"Mechanistically, LY6E downregulation suppresses the Wnt/β-catenin signaling pathway. This pathway activation is connected to enhanced pancreatic cancer growth and migration.\"}]","Lymphocyte antigen 6 family member E suppresses apoptosis and promotes pancreatic cancer growth and migration via Wnt/β‑catenin pathway activation | PDF",1790010003]